70 5.1.2.2 Activation en, p.72 ,
101 1.3.1 Fin du premier trimestre et début du deuxième trimestre ,
106 1.4.1 Fin du premier trimestre et début du deuxième trimestre ,
119 2.1.5 Corrélation entre l'expression de Phospho-AKT et de, p.121 ,
Eosine, Safran) 1.2.1 Fin du premier trimestre et début du deuxième trimestre ,
aucune cellule ne l'exprime au niveau de l'urothélium, contrairement à Phospho-mTOR où seules les cellules parapluies sont positives ,
caryotype : 46,XX) a été complétée par une analyse chromosomique sur puce à ADN mettant en évidence la délétion 17q12 du gène HNF1b ,
net/fr/sciences- terre-vie/biologie/nephron/ 6. Glomérule rénale. [Image] Disponible le 15/08/2017 sur : https://gecni.medixen.fr/images/glomerule-renale 7. Publication du CUEN. Physiologie et physiopathologie rénales, Disponible le 15, 2017. ,
Color Atlas of Fetal and Neonatal Histology, 2011. ,
DOI : 10.1007/978-1-4614-0019-6
Atlas de poche d'embryologie. Médecine-Sciences Flammarion, 1994. ,
Keeling's Fetal and neonatal pathology Cinquième édition. 882 p. 13. Mouse kidney development. [Image] Disponible le 15, Renal System Development -Embryology. [Image]. Disponible le 15, 2002. ,
American Registry of Pathology Orphanet: Syndrome rein colobome Disponible le 15 Orphanet: Syndrome de Kallmann Disponible le 15/08/2017 sur : http://www.orpha.net/consor Therapeutic Targets In Polycystic Liver Disease Mutations in MKKS cause Bardet-Biedl syndrome Le spectre des maladies par-mutations, Curr Drug Targets BARDET-BIEDL SYNDROME Nat Genet, vol.2126, issue.61, pp.15-21, 2000. ,
PI3K-AKT-mTOR pathway and cancer]. Bull Cancer (Paris), Feb, vol.199, issue.2, pp.173-80, 2012. ,
La voie de signalisation PI3K-AKT-mTOR??: description, d??veloppement th??rapeutique, r??sistances, marqueurs pr??dictifs/pronostiques et applications th??rapeutiques en canc??rologie, Bulletin du Cancer, vol.103, issue.1, 2016. ,
DOI : 10.1016/j.bulcan.2015.09.011
Opposite Translational Control of GLUT1 and GLUT4 Glucose Transporter mRNAs in Response to Insulin, Journal of Biological Chemistry, vol.269, issue.46, pp.33085-91, 1999. ,
DOI : 10.1172/JCI115068
Renal-Cell Carcinoma ??? Molecular Pathways and Therapies, New England Journal of Medicine, vol.356, issue.2 ,
DOI : 10.1056/NEJMe068263
AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint, Molecular Cell, vol.30, issue.2, pp.214-240, 2008. ,
DOI : 10.1016/j.molcel.2008.03.003
Mammalian target of rapamycin inhibition in polycystic kidney disease: From bench to bedside, Kidney Research and Clinical Practice, vol.31, issue.3, p.132, 2012. ,
DOI : 10.1016/j.krcp.2012.07.002
An experimental study of the organogenesis of the lung: the nature and specificity of the epithelio-mesenchymatous interactions], J Embryol Exp Morphol, vol.20, issue.2, pp.151-67, 1968. ,
Specific expression of the Hox 1.3 homeo box gene in murine embryonic structures originating from or induced by the mesoderm, EMBO J, vol.6, issue.10, pp.2965-75, 1987. ,
mTOR signalling, embryogenesis and the control of lung development, Seminars in Cell & Developmental Biology, vol.36, pp.68-78 ,
DOI : 10.1016/j.semcdb.2014.09.023
The branching programme of mouse lung development, Nature, vol.105, issue.7196, pp.745-50, 2008. ,
DOI : 10.1038/nature07005
Control of HIF-1?? and vascular signaling in fetal lung involves cross talk between mTORC1 and the FGF-10/FGFR2b/Spry2 airway branching periodicity clock, AJP: Lung Cellular and Molecular Physiology, vol.299, issue.4, pp.455-71, 2010. ,
DOI : 10.1152/ajplung.00348.2009
Defective Vascularization of HIF-1??-Null Embryos Is Not Associated with VEGF Deficiency but with Mesenchymal Cell Death, Developmental Biology, vol.209, issue.2, pp.254-67, 1999. ,
DOI : 10.1006/dbio.1999.9253
Negative and positive regulation of HIF-1: A complex network, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol.1755, issue.2, pp.107-127, 2005. ,
DOI : 10.1016/j.bbcan.2005.05.001
Role of oxygen and vascular development in epithelial branching morphogenesis of the developing mouse lung, AJP: Lung Cellular and Molecular Physiology, vol.288, issue.1, pp.167-178, 2005. ,
DOI : 10.1152/ajplung.00185.2004
Oxygen-sensing pathways and the development of mammalian gas exchange, Redox Report, vol.2000, issue.1, pp.325-365, 2003. ,
DOI : 10.1159/000242100
The role of amiloride-blockable sodium transport in adrenaline-induced lung liquid reabsorption in the fetal lamb., The Journal of Physiology, vol.376, issue.1, pp.321-361, 1986. ,
DOI : 10.1113/jphysiol.1986.sp016156
Development of the lung liquid reabsorptive mechanism in fetal sheep: synergism of triiodothyronine and hydrocortisone., The Journal of Physiology, vol.433, issue.1, pp.435-484, 1991. ,
DOI : 10.1113/jphysiol.1991.sp018436
Dysregulation of epithelial Na+ absorption induced by inhibition of the kinases TORC1 and TORC2, British Journal of Pharmacology, vol.277, issue.1, 2010. ,
DOI : 10.1074/jbc.M108951200
Developmental regulation of lumenal lung fluid and electrolyte transport, Respiratory Physiology & Neurobiology, vol.159, issue.3, pp.247-55, 2007. ,
DOI : 10.1016/j.resp.2007.10.004
Dietary l-arginine supplementation improves the intestinal development through increasing mucosal Akt and mammalian target of rapamycin signals in intra-uterine growth retarded piglets, British Journal of Nutrition, vol.36, issue.08, pp.1371-81, 2012. ,
DOI : 10.1203/00006450-199407001-00013
Regulation of translation initiation by insulin and amino acids in skeletal muscle of neonatal pigs, American Journal of Physiology - Endocrinology And Metabolism, vol.285, issue.1, pp.40-53, 2003. ,
DOI : 10.1152/ajpendo.00563.2002
Glutamine, arginine, and leucine signaling in the intestine, Amino Acids, vol.271, issue.Suppl, pp.111-133, 2009. ,
DOI : 10.1042/bj3360001
Dietary arginine supplementation enhances the growth of milk-fed young pigs, J Nutr, vol.134, issue.3, pp.625-655, 2004. ,
PI3K: Downstream AKTion Blocks Apoptosis, Cell, vol.88, issue.4, pp.435-442, 1997. ,
DOI : 10.1016/S0092-8674(00)81883-8
URL : http://doi.org/10.1016/s0092-8674(00)81883-8
Novel targets for the treatment of autosomal dominant polycystic kidney disease, Expert Opinion on Investigational Drugs, vol.280, issue.3, pp.315-343, 2010. ,
DOI : 10.1038/ki.1996.383
Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations, Drug Resistance Updates, vol.11, issue.1-2, p.32, 2008. ,
DOI : 10.1016/j.drup.2007.11.003
or both for advanced renal-cell carcinoma, N Engl J Med, vol.356, issue.22, pp.2271-81, 2007. ,
The role of S6K1 in ER-positive breast cancer. Cell Cycle, pp.3159-65, 2012. ,
The BOLERO-2 trial: the addition of everolimus to exemestane in the treatment of postmenopausal hormone receptor-positive advanced breast cancer, Future Oncology, vol.9, issue.6, pp.651-658 ,
DOI : 10.1093/jnci/djk020
Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis. Lung Cancer Amst Neth, Feb, vol.51, issue.2, pp.181-91, 2006. ,
Étude du profil mutationnel K-RAS, EGFR, LKB1 et de la transition épithélio-mésenchymateuse dans une série de 22 carcinomes sarcomatoïdes pulmonaires, Thèse de doctorat : médecine. Grenoble : Université Joseph Fourier. Disponible le 15, 2011. ,
mTOR Is Essential for Growth and Proliferation in Early Mouse Embryos and Embryonic Stem Cells, Molecular and Cellular Biology, vol.24, issue.15, pp.6710-6718, 2004. ,
DOI : 10.1128/MCB.24.15.6710-6718.2004
URL : http://mcb.asm.org/content/24/15/6710.full.pdf
Potential role of Akt signaling in chronic kidney disease. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc -Eur Ren Assoc, 2015. ,
Nuclear localized Akt enhances breast cancer stem-like cells through counter-regulation of p21(Waf1/Cip1) and p27(kip1), Cell Cycle Georget Tex, vol.14, issue.13, pp.2109-2129, 2015. ,
FRAP/mTOR is required for proliferation and patterning during embryonic development in the mouse, Proceedings of the National Academy of Sciences, vol.97, issue.26, pp.13796-801, 2001. ,
DOI : 10.1073/pnas.011511898
GDNF/Ret signaling and renal branching morphogenesis, Organogenesis, vol.129, issue.4, 2010. ,
DOI : 10.1016/j.ydbio.2007.08.021
URL : http://doi.org/10.1016/j.ydbio.2007.03.091
Phosphatidylinositol-3-Kinase/Akt Signaling Pathway and Kidney Cancer, and the Therapeutic Potential of Phosphatidylinositol-3-Kinase/Akt Inhibitors, The Journal of Urology, vol.182, issue.6, pp.2569-77, 2009. ,
DOI : 10.1016/j.juro.2009.08.085
Polycystin-1 Induces Resistance to Apoptosis through the Phosphatidylinositol 3-Kinase/Akt Signaling Pathway, Journal of the American Society of Nephrology, vol.17, issue.3, pp.637-684, 2006. ,
DOI : 10.1681/ASN.2005050534
Increased activated Akt expression in renal cell carcinomas and prognosis, Journal of Cellular and Molecular Medicine, vol.5, issue.8b, pp.2181-2189, 2009. ,
DOI : 10.3816/CGC.2007.n.020
URL : http://onlinelibrary.wiley.com/doi/10.1111/j.1582-4934.2008.00488.x/pdf
Molecular Pathogenetics of Renal Cancer, American Journal of Nephrology, vol.26, issue.3, pp.218-249, 2006. ,
DOI : 10.1159/000093631
Nuclear expression of hypoxia-inducible factor-1alpha in clear cell renal cell carcinoma is involved in tumor progression, Am J Surg Pathol, 2007. ,
Defining the role of mTOR in cancer. Cancer Cell, pp.9-22, 2007. ,
The role of the Birt???Hogg???Dub?? protein in mTOR activation and renal tumorigenesis, Oncogene, vol.11, issue.13, pp.1594-604, 2009. ,
DOI : 10.1038/ncb999
Characterization of Clinical Cases of Collecting Duct Carcinoma of the Kidney Assessed by Comprehensive Genomic Profiling, European Urology, vol.70, issue.3, pp.516-537, 2016. ,
DOI : 10.1016/j.eururo.2015.06.019
Collecting duct carcinoma of the kidney is associated with <i>CDKN2A</i> deletion and <i>SLC</i> family gene up-regulation, Oncotarget, vol.7, issue.21, pp.29901-29916, 2016. ,
DOI : 10.18632/oncotarget.9093
Développements actuels des inhibiteurs de mTOR en néphrologie et en transplantation rénale Disponible le 15/08/2017 sur : http://www.sfndt.org/sn Traditional and targeted exome sequencing reveals common, rare and novel functional deleterious variants in RET-signaling complex in a cohort of living US patients with urinary tract malformations, Hum Genet, vol.131, issue.11, pp.1725-1763, 2007. ,
Renal cysts in pediatric patients. A classification and overview ,
DOI : 10.1007/bf00858446
RET and GDNF mutations are rare in fetuses with renal agenesis or other severe kidney development defects, Journal of Medical Genetics, vol.48, issue.7, pp.497-504, 2011. ,
DOI : 10.1136/jmg.2010.088526
URL : https://hal.archives-ouvertes.fr/hal-00622876
Renal Aplasia in Humans Is Associated with RET Mutations, The American Journal of Human Genetics, vol.82, issue.2, 2008. ,
DOI : 10.1016/j.ajhg.2007.10.008
URL : http://doi.org/10.1016/j.ajhg.2007.10.008
The many faces of RET dysfunction in kidney, Organogenesis, vol.106, issue.4, pp.177-90, 2009. ,
DOI : 10.1016/S0092-8674(01)00422-6
Congenital Anomalies of the Kidney and Urinary Tract: A Genetic Disorder?, International Journal of Nephrology, vol.12, issue.11 ,
DOI : 10.1038/nrg3031
Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease, Disponible le 15, pp.2143-60, 2007. ,
Tuberin-Dependent Membrane Localization of Polycystin-1, Molecular Cell, vol.7, issue.4, pp.823-855, 2001. ,
DOI : 10.1016/S1097-2765(01)00226-X
URL : http://doi.org/10.1016/s1097-2765(01)00226-x
Loss of Tsc1, but not Pten, in renal tubular cells causes polycystic kidney disease by activating mTORC1, Human Molecular Genetics, vol.18, issue.22, 2009. ,
DOI : 10.1093/hmg/ddp398
Rapamycin Ameliorates PKD Resulting from Conditional Inactivation of Pkd1, Journal of the American Society of Nephrology, vol.21, issue.3, 2010. ,
DOI : 10.1681/ASN.2009040421
URL : http://jasn.asnjournals.org/content/21/3/489.full.pdf
Sirolimus attenuates disease progression in an orthologous mouse model of human autosomal dominant polycystic kidney disease, Kidney International, vol.78, issue.8, pp.754-61, 2010. ,
DOI : 10.1038/ki.2010.250
Therapeutic approaches in autosomal dominant polycystic kidney disease (ADPKD): is there light at the end of the tunnel? Nephrol Dial Transplant, pp.1752-1759, 2006. ,
Sirolimus and Kidney Growth in Autosomal Dominant Polycystic Kidney Disease, New England Journal of Medicine, vol.363, issue.9, pp.820-829, 2010. ,
DOI : 10.1056/NEJMoa0907419
URL : http://www.zora.uzh.ch/id/eprint/34854/4/Sirolimus_and_kidney_growth_in_autosomal_dominant_polycystic_2010.pdf
Everolimus Retards Cyst Growth and Preserves Kidney Function in a Rodent Model for Polycystic Kidney Disease, Kidney and Blood Pressure Research, vol.30, issue.4, pp.253-262, 2007. ,
DOI : 10.1159/000104818
Activation of the AKT/mTOR pathway in autosomal recessive polycystic kidney disease (ARPKD) Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc -Eur Ren Assoc, pp.1819-1846, 2009. ,
Food Restriction Ameliorates the Development of Polycystic Kidney Disease, Journal of the American Society of Nephrology, vol.27, issue.5, pp.1437-1484, 2016. ,
DOI : 10.1681/ASN.2015020132
The Bardet???Biedl syndrome-related protein CCDC28B modulates mTORC2 function and interacts with SIN1 to control cilia length independently of the mTOR complex, Human Molecular Genetics, vol.22, issue.20, pp.4031-4073, 2013. ,
DOI : 10.1093/hmg/ddt253
A review on hepatocyte nuclear factor-1beta and tumor, Cell & Bioscience, vol.119, issue.7, p.58, 2015. ,
DOI : 10.1172/JCI37028
URL : http://doi.org/10.1186/s13578-015-0049-3
Genetic disorders of human congenital anomalies of the kidney and urinary tract (CAKUT). Pediatr Int Off J Jpn Pediatr Soc, 2003. ,